[
    "{\"step_by_step_thinking\": \"Based on the information provided in the documents, we can conclude that dupilumab has been FDA approved for the treatment of atopic dermatitis. Document [2] states that dupilumab received its first global approval in the USA for the treatment of adult patients with moderate-to-severe atopic dermatitis. Document [5] also mentions that dupilumab was approved by the FDA for the treatment of moderate-to-severe atopic dermatitis in adults. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]